Validation of tissue microarray biomarker expression of breast carcinomas in Saudi women

Hematology/ Oncology and Stem Cell Therapy

Volumn 2, Issue 3, 2009, Pages 394-398

  Alkushi, Abdulmohsen ^a  

^a KING SAUD BIN ABDULAZIZ UNIVERSITY FOR HEALTH SCIENCES   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; EOSIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; HEMATOXYLIN; PROGESTERONE RECEPTOR; PROTEIN P53; ERBB2 PROTEIN, HUMAN; TP53 PROTEIN, HUMAN; TUMOR MARKER;

ARTICLE; BREAST CARCINOMA; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PROTEIN EXPRESSION; RECIPIENT; TISSUE MICROARRAY; VALIDATION STUDY; BREAST TUMOR; ENZYME IMMUNOASSAY; METABOLISM; PAGET NIPPLE DISEASE; PATHOLOGY; PROGNOSIS; SAUDI ARABIA;

BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; PROGNOSIS; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; SAUDI ARABIA; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 77953673809     PISSN: 16583876     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1658-3876(09)50007-6     Document Type: Article

References (17)

1. Kononen J, Bubendorf L, Kallioniemi A, Barlund M, Schraml P, Leighton S, Torhorst J, Mihatsch MJ, Sauter G, Kallioniemi OP. Tissue microarrays for high throughput molecular profiling of tumor specimens. Nat Med 1998;4:844-7.
2. Van de Rijn M, Gilks CB. Applications of microarrays to histopathology. Histopathology. 2004 Feb;44(2):97-108.
3. Moch H, Kononen T, Kallioniemi OP, Sauter G. Tissue microarrays: what will they bring to molecular and anatomic pathology? Adv Anat Pathol. 2001 Jan;8(1):14-20.
4. Camp RL, Charette LA, Rimm DL. Validation of tissue microarray technology in breast carcinoma. Lab Invest 2000;80:1943-9.
5. Gulmann C, Butler D, Kay E, Grace A, Leader M. Biopsy of a biopsy: validation of immunoprofiling in gastric cancer biopsy tissue microarrays. Histopathology 2003;42:70-6.
6. Zaino RJ, Clarke CL, Mortel R, Satyaswaroop PG. Heterogeneity of progesterone receptor distribution in human endometrial adenocarcinoma. Cancer Res 1988;48:1889-95.
7. Ni R, Mulligan AM, Have C, O'Malley FP. PGDS, a novel technique combining chromogenic in situ hybridization and immunohistochemistry for the assessment of ErbB2 (HER 2/neu) status in breast cancer. Appl Immunohistochem Mol Morphol. 2007 Sep;15(3):316-24.
8. Dawson B, Trapp RG. Basic and Clinical Biostatistics. New York: Lange Medical Books/McGraw-Hill, 2004.
9. Lax SF, Pizer ES, Ronnett BM, Kurman RJ. Comparison of estrogen and progesterone receptor, Ki-67, and p53 immunoreactivity in uterine endometrioid carcinoma and endometrioid carcinoma with squamous, mucinous, secretory, and ciliated cell differentiation. Hum Pathol 1998;29:924-31.
10. Nocito A, Bubendorf L, Maria TE, Suess K, Wagner U, Forster T, Kononen J, Fijan A, Bruderer J, Schmid U, Ackermann D, Maurer R, Alund G, Knonagel H, Rist M, Anabitarte M, Hering F, Hardmeier T, Schoenenberger AG, Flury R, Jager P, Luc FJ, Schraml P, Moch H, Mihatsch MJ, Gasser T, Sauter G. Microarrays of bladder cancer tissue are highly representative of proliferation index and histological grade. J Pathol 2001;194:349-57.
11. Fitzgibbons PL, Page DL, Weaver D, et al. Prognostic factors in breast cancer. College of American Pathologist Consensus Statement 1999. Arch Pathol Lab Med 2000;124:966-978.
12. Fons G, van der Velden J, Burger M, ten Kate F. Validation of tissue microarray technology in vulvar cancer. Int J Gynecol Pathol. 2009; 28(1):76-82.
13. Hoos A, Urist MJ, Stojadinovic A, Mastorides S, Dudas ME, Leung DH, Kuo D, Brennan MF, Lewis JJ, Cordon-Cardo C. Validation of tissue microarrays for immunohistochemical profiling of cancer specimens using the example of human fibroblastic tumors. Am J Pathol 2001;158:1245-51.
14. Fernebro E, Dictor M, Bendahl PO, Fernö M, Nilbert M. Evaluation of the tissue microarray technique for immunohistochemical analysis in rectal cancer. Arch Pathol Lab Med. 2002;126(6):702-5.
15. Rosen DG, Huang X, Deavers MT, Malpica A, Silva EG, Liu J. Validation of tissue microarray technology in ovarian carcinoma. Mod Pathol. 2004; 17(7):790-7.
16. Ruiz C, Seibt S, Al Kuraya K, Siraj AK, Mirlacher M, Schraml P, Maurer R, Spichtin H, Torhorst J, Popovska S, Simon R, Sauter G. Tissue microarrays for comparing molecular features with proliferation activity in breast cancer. Int J Cancer. 2006 May 1;118(9):2190-4.
17. Goethals L, Perneel C, Debucquoy A, De Schutter H, Borghys D, Ectors N, Geboes K, McBride WH, Haustermans KM. A new approach to the validation of tissue microarrays. J Pathol. 2006;208(5):607-14.